¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

¼øõÇâ ÀÇÇבּ¸ Çмú´ëȸ 2020 : 2020-11-08

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
¼øõÇâ ÀÇÇבּ¸ Çмú´ëȸ 2020 : 2020-11-08
±³À°ÀÏÀÚ : 2020-11-08
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°  
±³À°ÁÖÁ¦ : ¼øõÇâ ÀÇÇבּ¸ Çмú´ëȸ 2020      
ÁÖÃÖ±â°ü : ¼øõÇâ´ëÇм­¿ïº´¿ø
´ã´çÀÚ : ±èº¸¹è 
¿¬¶ôó 02-710-3155  
À̸ÞÀÏ : schirb@schmc.ac.kr      
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, »êºÎÀΰú, Á¤½Å°Ç°­ÀÇÇаú, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú, ¼ºÇü¿Ü°ú, À̺ñÀÎÈÄ°ú, ÇǺΰú, Áø´Ü°Ë»çÀÇÇаúÀÇ»çÇÐ, ÇغÎÇÐ, ÀÇ·áÄ¿¹Â´ÏÄÉÀ̼Ç, ÀÇÇб³À°, ±âŸ,      
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 4Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 10ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í       
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11¿ù 08ÀÏ ºñ´ë¸é È­»ó °­ÀÇ 09:00~10:00 New Therapeutic Strategies to Conquer Hepatitis B Virus  ¾È»óÈÆ(¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ½ÅÃ̼¼ºê¶õ½ºº´¿ø) 
±³À°½Ã°£ 11¿ù 08ÀÏ ºñ´ë¸é È­»ó °­ÀÇ 10:00~10:30 Targeting Cancer Stem Cells and Current Trends  ±ÇÇõ¿µ(¼øõÇâ ÀÇ»ý¸íÀ¶ÇÕÇаú(SIMS)) 
Åä·Ð 11¿ù 08ÀÏ ºñ´ë¸é È­»ó °­ÀÇ 10:30~10:40 Q & A  ¼­Ã¢¼ö(¼øõÇâ´ëÇб³) 
Åä·Ð 11¿ù 08ÀÏ ºñ´ë¸é È­»ó °­ÀÇ 10:30~10:40 Q & A  º¯µ¿¿ø(¼øõÇâ´ëÇб³ ºÎ¼Ó ¼­¿ïº´¿ø) 
È޽Ġ11¿ù 08ÀÏ ºñ´ë¸é È­»ó °­ÀÇ 10:40~11:00 È޽Ġ ÈÞ½Ä(ÈÞ½Ä) 
±³À°½Ã°£ 11¿ù 08ÀÏ ºñ´ë¸é È­»ó °­ÀÇ 11:00~11:40 À¶ÇÕ¿¬±¸ÀÇ ÀÌÇØ¿Í Àû¿ë On the Road to Convergence Research  ÀÓÈ¿±Ù(¼º±Õ°üÀÇ´ë »ï¼ºÀ¶ÇÕÀÇ°úÇпø) 
±³À°½Ã°£ 11¿ù 08ÀÏ ºñ´ë¸é È­»ó °­ÀÇ 11:40~12:20 À¶ÇÕ¿¬±¸¸¦ ÅëÇÑ »õ·Î¿î ÀÇ·á ¼ö¿ä âÁ¶ The Idea to an Idealization of Medical Devices with 3D Printing for Generalizing Patient-Surgeon-Specific Medicine  ±è³²±¹(¿ï»êÀÇ´ë ¼­¿ï¾Æ»êº´¿ø) 
Åä·Ð 11¿ù 08ÀÏ ºñ´ë¸é È­»ó °­ÀÇ 12:20~12:30 Q&A  À±Á¤±³(¼øõÇâ ÀÇ»ý¸íÀ¶ÇÕÇаú(SIMS)) 
Åä·Ð 11¿ù 08ÀÏ ºñ´ë¸é È­»ó °­ÀÇ 12:20~12:30 Q & A  Å¹¹Î¼º(¼øõÇâ´ëÇб³ ºÎ¼Ó ¼­¿ïº´¿ø) 
½Ä»ç 11¿ù 08ÀÏ ºñ´ë¸é È­»ó °­ÀÇ 12:30~13:30 ½Ä»ç  () 
±³À°½Ã°£ 11¿ù 08ÀÏ ºñ´ë¸é È­»ó °­ÀÇ 13:30~13:50 Beyond Signal Inhibition: Multilateral Combat Strategies against Progression of Head & Neck Cancer  º¯Çü±Ç(¼øõÇâ´ëÇб³ ºÎ¼Ó ¼­¿ïº´¿ø) 
±³À°½Ã°£ 11¿ù 08ÀÏ ºñ´ë¸é È­»ó °­ÀÇ 13:50~14:10 Imaging-based Translational Research in Neurological Diseases  ÀÌÀͼº(¼øõÇâ´ëÇб³ ºÎ¼Ó ºÎõº´¿ø) 
±³À°½Ã°£ 11¿ù 08ÀÏ ºñ´ë¸é È­»ó °­ÀÇ 14:10~14:30 The Mechanism of AIM2 Inflammasome Activation and Their Role in the Pathogenesis of Psoriasis  ±èÁ¤Àº(¼øõÇâ´ëÇб³ ºÎ¼Ó õ¾Èº´¿ø) 
Åä·Ð 11¿ù 08ÀÏ ºñ´ë¸é È­»ó °­ÀÇ 14:30~14:40 Q&A  ÀÌÀº¿µ(¼øõÇâ´ëÇб³ ºÎ¼Ó õ¾Èº´¿ø) 
Åä·Ð 11¿ù 08ÀÏ ºñ´ë¸é È­»ó °­ÀÇ 14:30~14:40 Q & A  ±èÁø±¹(¼øõÇâ´ëÇб³ ºÎ¼Ó ºÎõº´¿ø) 
È޽Ġ11¿ù 08ÀÏ ºñ´ë¸é È­»ó °­ÀÇ 14:40~14:50 È޽Ġ ÈÞ½Ä(ÈÞ½Ä) 
±³À°½Ã°£ 11¿ù 08ÀÏ ºñ´ë¸é È­»ó °­ÀÇ 14:50~15:05 ¿Â¿­¿ä¹ýÀÌ »ý¹°ÇÐÀû ÇÁ·ÎÆÄÀÏ¿¡ ¹ÌÄ¡´Â ¿µÇâ - Ç÷Áß irisin ³óµµ¿Í lipid profileÀ» Áß½ÉÀ¸·Î Effect of thermotherapy on biological profile - focusing on circulating irisin and lipid profile  ¹ÚÅÂȯ(¼øõÇâ´ëÇб³ ÀÇÇаú) 
±³À°½Ã°£ 11¿ù 08ÀÏ ºñ´ë¸é È­»ó °­ÀÇ 15:05~15:20 FOXO3°¡ miRNA-22 ¹ßÇö¿¡ ¹ÌÄ¡´Â ¿µÇâ The effect of FOXO3 on the expression of miRNA-22  À¯°æÇö(¼øõÇâ´ëÇб³ ÀÇÇаú) 
±³À°½Ã°£ 11¿ù 08ÀÏ ºñ´ë¸é È­»ó °­ÀÇ 15:20~15:35 Histomorphologic investigation of adults cadaveric vertebro-basilar arteries: Its implications for the vessel pathology  ÀÌÁ¦È£(¼øõÇâ´ëÇб³ ÀÇÇаú) 
±³À°½Ã°£ 11¿ù 08ÀÏ ºñ´ë¸é È­»ó °­ÀÇ 15:35~15:50 Correlations of autistic-like phenotype and altered hippocampal property following febrile seizure  À̼±¿õ(¼øõÇâ´ëÇб³ ÀÇÇаú) 
±³À°½Ã°£ 11¿ù 08ÀÏ ºñ´ë¸é È­»ó °­ÀÇ 15:50~16:10 Role of Pyridoxine on Hippocampal Neurogenesis  À¯´ë¿µ(¼øõÇâÀÇ°ú´ëÇÐ ÇغÎÇб³½Ç) 
±³À°½Ã°£ 11¿ù 08ÀÏ ºñ´ë¸é È­»ó °­ÀÇ 16:10~16:30 Genetic Approaches for Identifying Novel Regulators during Respiratory Development and Homeostasis  ±èÇöÅÃ(¼øõÇâ ÀÇ»ý¸íÀ¶ÇÕÇаú(SIMS)) 
±³À°½Ã°£ 11¿ù 08ÀÏ ºñ´ë¸é È­»ó °­ÀÇ 16:30~16:50 3D ¹ÙÀÌ¿À ÇÁ¸°Æà ½Ã½ºÅÛ°ú ÀÀ¿ë 3D Bioprinting System and its Application  ±Ç°è½Ã(¼øõÇâ´ëÇб³ ±â°è°øÇаú) 
Åä·Ð 11¿ù 08ÀÏ ºñ´ë¸é È­»ó °­ÀÇ 16:50~17:00 Q&A  ±èµ¿ÇÐ(¼øõÇâ´ëÇб³) 
Åä·Ð 11¿ù 08ÀÏ ºñ´ë¸é È­»ó °­ÀÇ 16:50~17:00 Q & A  ¹é¹«ÁØ(¼øõÇâ´ëÇб³ ºÎ¼Ó õ¾Èº´¿ø) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ¼øõÇâ ÀÇÇבּ¸ Çмú´ëȸ 2020 : 2020-11-08""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) 2020³â ´ëÇÑ¿Ü°úÀÇ»çȸ Ã߰迬¼ö°­Á : 2020-11-08
´ÙÀ½±Û Á¦33ȸ ´ëÇѳëÀÎÀÇÇÐȸ Ãß°èÇмú´ëȸ (¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ ±³À°) : 2020-11-08
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
195 ´ë±¸ ´ë±¸°¡Å縯´ëÇб³º´¿ø ÀÏÂ÷Áø·á¿¡¼­ ÈçÈ÷ º¸´Â ·ù¸¶Æ¼½ºÁúȯÀÇ °¨º°Áø´Ü ¹× Ä¡·á ¹Ù·Î ¾Ë±â : 2018-09-02 0 939 2018-07-28
194 ¼­¿ï ´ëÇÑÀçÈ°ÀÇÇÐȸ Ã߰迬¼ö°­Á : 2018-09-02 0 392 2018-07-28
193 °æ±â ºÐ´ç¼­¿ï´ëÇб³º´¿ø ¾È°úÁúȯÀÇ ÃÖ½ÅÁö°ß : 2018-09-02 0 2,310 2018-07-28
192 ¼­¿ï Á¦21ȸ ¼­¿ï¾Æ»êº´¿ø ³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2018-09-02 0 786 2018-07-28
191 ¼­¿ï »ï¼º¼­¿ïº´¿ø Á¦21ȸ »ï¼º ºÎºñµ¿ ³»½Ã°æ¼ö¼ú ½ÉÆ÷Áö¾ö : 2018-09-02 0 625 2018-07-28
190 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø SNUH 3A(Anesthesiology Alumni Annual)Update : 2018-09-01 0 541 2018-07-28
189 ¼­¿ï °­ºÏ»ï¼ºº´¿ø ¾È°úÇб³½Ç ½ÉÆ÷Áö¾ö : 2018-09-01 0 666 2018-07-28
188 ºÎ»ê 2018 ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ ±¹Á¦Çмú´ëȸ(9¿ù 1ÀÏ) : 2018-09-01 0 570 2018-07-28
187 Á¦ÁÖ ´ëÇÑ°£ÇÐȸ °£Áúȯ ÃֽŠÁö°ß update : 2018-09-01 0 435 2018-07-28
186 ¼­¿ï ´ëÇѺñ´¢±â°úÇÐȸ 2018 KPS-APSU Joint International Symposium : 2018-09-01 0 643 2018-07-28
185 °­¿ø ´ëÇѽŻý¾ÆÇÐȸ Á¦9Â÷ ±³À°¼¼¹Ì³ª ¥± : 2018-09-01 0 391 2018-07-28
184 °æ³² 2018 ºÎ»ê¿ï»ê°æ³² ¼Ò¾Æ½Å°æÁöȸ ½ÉÆ÷Áö¾ö: IMPROVING MANAGEMENT SKILLS IN PEDIATRIC NEUROLOGY : 2018-09-01 0 702 2018-07-28
183 ¼­¿ï 2018³âµµ Çѱ¹Á¤½ÅÄ¡·áÇÐȸ Á¦10ȸ Àü°øÀǸ¦ À§ÇÑ Á¤½ÅÄ¡·á ¿öÅ©¼ó : 2018-09-01 0 801 2018-07-28
182 °æ±â Á¦1ȸ ¸íÁöº´¿ø ½Å°æ°ú ½ÉÆ÷Áö¾ö -ÀÏÂ÷Áø·á¿¡¼­ ÈçÈ÷ Á¢ÇÏ´Â ½Å°æ°ú Áúȯ : 2018-09-01 0 835 2018-07-28
181 °­¿ø 2018³â ´ëÇѺ¸Á¶»ý½ÄÇÐȸ Á¦32Â÷ Çмú´ëȸ : 2018-09-01 0 763 2018-07-28
1391 | 1392 | 1393 | 1394 | 1395 | 1396 | 1397 | 1398 | 1399 | 1400
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷